Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCohi-O Lenses in Chronic Ocular GVHD
ChiCTR2500100196Phase 2Not yet recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Apr 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of Stem Cells Lenses in graft-versus-host disease (GVHD) (7 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: Adverse events. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
Stem Cells Lenses
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on ChiCTR2500100196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500100196.